Genetically Engineered Salmon Labeling Act
This bill requires the market name of genetically engineered (commonly called genetically modified or GMO) salmon to include Genetically Engineered or GE in front of the existing market name.
The bill also requires the Department of Health and Human Services to ensure that an independent scientific organization reviews the Food and Drug Administration's environmental assessment that supports the approval of a new drug related to AquAdvantage Salmon, a type of genetically engineered salmon.
To amend the market name of genetically altered salmon in the United 
                    States, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Genetically Engineered Salmon 
Labeling Act''.

SEC. 2. PURPOSES.

    It is the purpose of this Act to--
            (1) ensure that consumers in the United States can make 
        informed decisions when purchasing salmon; and
            (2) authorize an independent scientific review of--
                    (A) the possible effects of genetically engineered 
                salmon on wild salmon stocks; and
                    (B) the Food and Drug Administration's approval of 
                genetically engineered salmon for human consumption.

SEC. 3. MARKET NAME FOR GENETICALLY ENGINEERED SALMON.

    (a) In General.--Notwithstanding any other provision of law, for 
purposes of applying the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 301 et seq.), the acceptable market name of any salmon that is 
genetically engineered shall include the words ``Genetically 
Engineered'' or ``GE'' prior to the existing acceptable market name.
    (b) Definition.--For purposes of this section, salmon is 
genetically engineered if it has been modified by recombinant DNA 
(rDNA) techniques, including the entire lineage of salmon that contain 
the rDNA modification.

SEC. 4. THIRD-PARTY REVIEW OF CERTAIN SALMON APPROVAL.

    The Secretary of Health and Human Services shall ensure that an 
independent scientific organization conducts a review of the 
environmental assessment that was carried out by the Food and Drug 
Administration in support of an approval of a new animal drug 
application related to AquAdvantage Salmon, dated November 12, 2015.
                                 <all>
Genetically Engineered Salmon Labeling Act
To amend the market name of genetically altered salmon in the United States, and for other purposes.
Genetically Engineered Salmon Labeling Act
Rep. Young, Don